Bavarian Nordic A/S

Complaint initiates U.S. ITC investigation of patent infringement on smallpox vaccine products

Published in Medicine and Law Weekly, October 28th, 2005

After a 30-day review period of the complaint, the U.S. International Trade Commission (ITC) based in Washington, DC, instituted an investigation of patent infringement on MVA smallpox vaccine products marketed by Acambis plc.

The investigation is based on a complaint filed by Bavarian Nordic A/S on August 19, 2005 alleging that Acambis plc imported and sold, and/or offered to sell in the U.S., MVA smallpox vaccines that infringe patents owned by Bavarian Nordic. The complaint further alleges misappropriation of Bavarian Nordic's MVA-BN proprietary technology.

Bavarian Nordic is requesting the ITC to issue a permanent cease-and-desist order, which...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-10-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry